{"database": "openregs", "table": "documents", "rows": [["FDA-2014-D-1167-0012", "FDA", "FDA-2014-D-1167", "Controlled Correspondence Related to Generic Drug Development; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-09-29T04:00:00Z", 2015, 9, "2015-09-29T04:00:00Z", null, "2015-09-29T14:14:27Z", "2015-24621", 0, 0, "0900006481ca0e1f"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-D-1167-0012"], "units": {}, "query_ms": 96.04705707170069, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}